Prevalence and Effect of Genetic Risk of Thromboembolic Disease in Inflammatory Bowel Disease

NIDDK IBD Genetics Consortium

研究成果: Article査読

2 被引用数 (Scopus)


Background And Aims: The largest cause of mortality in patients with inflammatory bowel disease (IBD) remains thromboembolic disease (TED). Recent reports have demonstrated that both monogenic and polygenic factors contribute to TED and 10% of healthy subjects are genetically at high risk for TED. Our aim was to utilize whole-exome sequencing and genome-wide genotyping to determine the proportion of IBD patients genetically at risk for TED and investigate the effect of genetic risk of TED in IBD. Methods: The TED polygenic risk score was calculated from genome-wide genotyping. Thrombophilia pathogenic variants were extracted from whole-exome sequencing. In total, 792 IBD patients had both whole-exome sequencing and genotyping data. We defined patients at genetically high risk for TED if they had a high TED polygenic risk score or carried at least 1 thrombophilia pathogenic variant. Results: We identified 122 of 792 IBD patients (15.4%) as genetically high risk for TED. Among 715 of 792 subjects whose documented TED status were available, 63 of the 715 patients (8.8%) had TED events. Genetic TED risk was significantly associated with increased TED event (odds ratio, 2.5; P =.0036). In addition, we confirmed an additive effect of monogenic and polygenic risk on TED (P =.0048). Patients with high TED genetic risk more frequently had thrombosis at multiple sites (78% vs 42%, odds ratio, 3.96; P =.048). Conclusions: Genetic risk (both poly- and monogenic) was significantly associated with TED history. Our results suggest that genetic traits identify approximately 1 in 7 patients with IBD who will experience 2.5-fold or greater risk for TED.

出版ステータスPublished - 2021 2

ASJC Scopus subject areas

  • 肝臓学
  • 消化器病学


「Prevalence and Effect of Genetic Risk of Thromboembolic Disease in Inflammatory Bowel Disease」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。